Skip to main content
Subscribe
Log In
More
Log in via Institution
Log in via OpenAthens
Log in via your Society
Select your society
ESGO
IGCS
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
Latest content
Current issue
Archive
Authors
About
YouTube
Podcasts
Zoom Journal Club
Search for this keyword
Advanced search
Close
More
Main menu
Latest content
Current issue
Archive
Authors
About
YouTube
Podcasts
Zoom Journal Club
Subscribe
Log in
More
Log in via Institution
Log in via OpenAthens
Log in via your Society
Select your society
ESGO
IGCS
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
You are here
Home
Archive
Volume 29, Issue Suppl 3
38 Phase II study of enzalutamide in androgen receptor positive (AR+) recurrent ovarian cancer: final results
Email alerts
Article metrics
Article menu
Article
Text
Article
info
Citation
Tools
Share
Rapid Responses
Article
metrics
Alerts
PDF
Plenary sessions
Plenary 6
IGCS19-0174
38 Phase II study of enzalutamide in androgen receptor positive (AR+) recurrent ovarian cancer: final results
Free
Online download statistics by month:
Online download statistics by month: September 2019 to October 2024
Abstract
Full
Pdf
Sep 2019
24
0
9
Oct 2019
27
0
5
Nov 2019
16
0
3
Dec 2019
20
0
4
Jan 2020
6
0
1
Feb 2020
6
0
2
Mar 2020
8
0
2
Apr 2020
30
0
3
May 2020
16
0
1
Jun 2020
38
0
9
Jul 2020
21
0
3
Aug 2020
10
0
3
Sep 2020
32
0
3
Oct 2020
46
0
6
Nov 2020
44
0
3
Dec 2020
22
0
2
Jan 2021
42
0
8
Feb 2021
11
0
2
Mar 2021
26
0
2
Apr 2021
18
0
5
May 2021
3
0
3
Jun 2021
0
0
7
Jul 2021
0
0
2
Aug 2021
0
0
2
Sep 2021
0
0
3
Oct 2021
6
0
19
Nov 2021
26
0
14
Dec 2021
22
0
2
Jan 2022
14
0
1
Feb 2022
26
0
3
Mar 2022
18
0
0
Apr 2022
6
0
2
May 2022
24
0
11
Jun 2022
16
0
4
Jul 2022
12
0
1
Aug 2022
17
0
6
Sep 2022
13
0
6
Oct 2022
28
0
2
Nov 2022
8
0
3
Dec 2022
24
0
1
Jan 2023
4
0
1
Feb 2023
18
0
3
Mar 2023
16
0
2
Apr 2023
10
0
2
May 2023
11
0
1
Jun 2023
4
0
0
Jul 2023
14
0
3
Aug 2023
6
0
4
Sep 2023
10
0
1
Oct 2023
5
0
0
Nov 2023
18
0
2
Dec 2023
13
0
0
Jan 2024
8
0
1
Feb 2024
14
0
2
Mar 2024
21
0
19
Apr 2024
6
0
4
May 2024
10
0
2
Jun 2024
13
0
0
Jul 2024
6
0
0
Aug 2024
12
0
5
Sep 2024
8
0
2
Oct 2024
4
0
0
Total
957
0
222
Read the full text or download the PDF:
Subscribe
Log in
Log in via Institution
Log in via OpenAthens
Log in via your Society
Select your society
ESGO
IGCS
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?